Adam Dubow Day One Biopharmaceuticals, Inc. (DAWN) insider trading activity

Adam Dubow is Gen Counsel & Secretary of Day One Biopharmaceuticals, Inc.. Currently has a direct ownership of 62,626 shares of DAWN, which is worth approximately $551,108. The most recent transaction as insider was on Nov 17, 2025, when has been sold 4,319 shares (Common Stock) at a price of $8.91 per share, resulting in proceeds of $38,482. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 62.6K

14.16% 3M change

94.72% 12M change

Total Value Held $551,108

Adam Dubow Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 17 2025	SELL Open market or private sale	$38,482 $8.91 p/Share	4,319 Reduced 6.45%	62,626 Common Stock
Nov 15 2025	BUY Exercise of conversion of derivative security	-	12,087 Added 15.29%	66,945 Common Stock
Aug 18 2025	SELL Open market or private sale	$29,551 $6.77 p/Share	4,365 Reduced 7.37%	54,858 Common Stock
Aug 15 2025	BUY Exercise of conversion of derivative security	-	12,087 Added 16.95%	59,223 Common Stock
May 16 2025	SELL Open market or private sale	$28,495 $6.26 p/Share	4,552 Reduced 8.81%	47,136 Common Stock
May 15 2025	BUY Exercise of conversion of derivative security	-	12,086 Added 18.95%	51,688 Common Stock
Feb 18 2025	SELL Open market or private sale	$55,566 $11.96 p/Share	4,646 Reduced 10.5%	39,602 Common Stock

Feb 15 2025	BUY Exercise of conversion of derivative security	-	12,086 Added 21.45%	44,248 Common Stock
Nov 18 2024	SELL Open market or private sale	$41,809 $13.21 p/Share	3,165 Reduced 8.96%	32,162 Common Stock
Nov 15 2024	BUY Exercise of conversion of derivative security	-	8,399 Added 19.21%	35,327 Common Stock
Aug 16 2024	SELL Open market or private sale	$44,828 $14.0 p/Share	3,202 Reduced 10.63%	26,928 Common Stock
Aug 15 2024	BUY Exercise of conversion of derivative security	-	8,399 Added 21.8%	30,130 Common Stock
May 16 2024	SELL Open market or private sale	$52,308 $16.08 p/Share	3,253 Reduced 13.02%	21,731 Common Stock
May 15 2024	BUY Exercise of conversion of derivative security	-	8,399 Added 25.16%	24,984 Common Stock
Feb 16 2024	SELL Open market or private sale	$49,440 $15.25 p/Share	3,242 Reduced 16.35%	16,585 Common Stock
Feb 15 2024	BUY Exercise of conversion of derivative security	-	8,399 Added 29.76%	19,827 Common Stock
Nov 16 2023	SELL Open market or private sale	$62,108 $11.69 p/Share	5,313 Reduced 31.74%	11,428 Common Stock
Nov 15 2023	BUY Exercise of conversion of derivative security	-	13,600 Added 44.82%	16,741 Common Stock

Also insider at

BMY

BRISTOL MYERS SQUIBB CO Healthcare

SVP,ChiefCompliance&EthicsOff.

Adam Dubow

Gen Counsel & Secretary

New York, NY

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DAWN shares.

Notify only if

Value

Insider Trading

Get notified when an Day One Biopharmaceuticals, Inc. insider buys or sells DAWN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Day One Biopharmaceuticals, Inc.

Track Activities on DAWN

Account